Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
Medicine name | beclometasone dipropionate (Beclu®) |
Formulation | inhalation solution |
Reference number | 5294 |
Indication | For the prophylactic management of mild, moderate, or severe asthma in adults or children: Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis. Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone. Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms |
Company | Lupin Healthcare (UK) Ltd |
BNF chapter | Respiratory system |
Assessment type | N/A |
Status | Medicine does not meet criteria for AWMSG assessment |
Date of issue | 04/07/2023 |